Acelyrin Inc
(SLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 59,855 | 85,712 | 54,747 | 93,025 | 82,774 |
| Operating Income | -59,855 | -85,712 | -54,747 | -93,025 | -82,774 |
| Other Income | 4,591 | 6,679 | 6,199 | 7,353 | 47,801 |
| Pre-tax Income | -55,264 | -79,033 | -48,548 | -85,672 | -34,973 |
| Net Income Continuous | -55,264 | -79,033 | -48,548 | -85,672 | -34,973 |
| Net Income | $-55,264 | $-79,033 | $-48,548 | $-85,672 | $-34,973 |
| EPS Basic Total Ops | -0.55 | -0.79 | -0.49 | -0.86 | -0.36 |
| EPS Basic Continuous Ops | -0.55 | -0.79 | -0.49 | -0.86 | -0.36 |
| EPS Diluted Total Ops | -0.55 | -0.79 | -0.49 | -0.86 | -0.36 |
| EPS Diluted Continuous Ops | -0.55 | -0.79 | -0.49 | -0.86 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.79 | -0.49 | -0.86 | -0.36 |
| EBITDA(a) | $-61,380 | $-88,869 | $-59,336 | $-97,962 | $-88,081 |